CD69−/− transgenic mice showed increased numbers of Th17 cells, higher expression of IL-17, and enhanced peritoneal fibrosis compared to wild-type mice in a PDF-treated model. This evidence concerns the gene IL17A and Peritoneal Fibrosis.